These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8605671)

  • 1. Quantitative immunoassay for complexes of prostate-specific antigen with alpha2-macroglobulin.
    España F; Sánchez-Cuenca J; Estellés A; Gilabert J; Griffin JH; Heeb MJ
    Clin Chem; 1996 Apr; 42(4):545-50. PubMed ID: 8605671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of prostate cancer: diagnostic and prognostic utility of prostate-specific antigen, alpha2-macroglobulin, and their complexes.
    Kanoh Y; Ohtani N; Ohara T; Mashiko T; Ohtani S; Egawa S; Baba S; Ohtani H
    Oncol Rep; 2001; 8(3):515-9. PubMed ID: 11295072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy.
    Lilja H; Haese A; Björk T; Friedrich MG; Piironen T; Pettersson K; Huland E; Huland H
    J Urol; 1999 Dec; 162(6):2029-34; discussion 2034-5. PubMed ID: 10569562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic potential of a PSA complex in sera of prostate cancer patients with alpha2-macroglobulin deficiency.
    Kanoh Y; Ohara T; Egawa S; Baba S; Akahoshi T
    J Clin Lab Anal; 2008; 22(4):302-6. PubMed ID: 18623104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen and its complexes with alpha 1-antichymotrypsin in the plasma of patients with prostatic disease.
    España F; Martínez M; Sánchez-Cuenca J; Vera CD; Estellés A; Jiménez-Cruz JF
    Eur Urol; 1996; 30(4):512-8. PubMed ID: 8977078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of purified prostate specific antigen to serum from female subjects: studies on the relative inhibition by alpha 2-macroglobulin and alpha 1-antichymotrypsin.
    Chen Z; Komatsu K; Prestigiacomo A; Stamey TA
    J Urol; 1996 Oct; 156(4):1357-63. PubMed ID: 8808871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological characteristics of androgen-dependent advanced prostate cancer patients with α2-macroglobulin deficiency.
    Kanoh Y; Ohtani H; Egawa S; Baba S; Akahoshi T
    Int J Oncol; 2012 Jul; 41(1):39-45. PubMed ID: 22576683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative ELISA for the measurement of complexes of prostate-specific antigen with protein C inhibitor when using a purified standard.
    España F; Sanchez-Cuenca J; Vera CD; Estelles A; Gilabert J
    J Lab Clin Med; 1993 Dec; 122(6):711-9. PubMed ID: 7504042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of proteases and proteinase inhibitors in androgen-dependent advanced prostate cancer patients with alpha2-macroglobulin deficiency.
    Kanoh Y; Ohtani H; Egawa S; Baba S; Akahoshi T
    Clin Lab; 2012; 58(3-4):217-25. PubMed ID: 22582494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reference range for complexed alpha 2-macroglobulin human plasma: development of a new enzyme linked in immunosorbent assay (ELISA) for quantitation of complexed alpha 2-macroglobulin.
    Jespersen MH; Jensen J; Rasmussen LH; Ejlersen E; Møller-Petersen J; Sperling-Petersen HU
    Scand J Clin Lab Invest; 1993 Oct; 53(6):639-48. PubMed ID: 7505478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen triggers transformation of seminal alpha2-macroglobulin (alpha2-M) and its binding to alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein (alpha2-M-R/LRP) on human spermatozoa.
    Birkenmeier G; Usbeck E; Schäfer A; Otto A; Glander HJ
    Prostate; 1998 Sep; 36(4):219-25. PubMed ID: 9719021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of IgG N-linked oligosaccharide chains and proteases in sera of prostate cancer patients with and without alpha2-macroglobulin deficiency.
    Kanoh Y; Egawa S; Baba S; Akahoshi T
    J Clin Lab Anal; 2009; 23(2):125-31. PubMed ID: 19288446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen forms a complex with and cleaves alpha 1-protease inhibitor in vitro.
    Zhang WM; Leinonen J; Kalkkinen N; Stenman UH
    Prostate; 1997 Oct; 33(2):87-96. PubMed ID: 9316649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and immunological determination of the complex between prostate-specific antigen and alpha2-macroglobulin.
    Zhang WM; Finne P; Leinonen J; Vesalainen S; Nordling S; Rannikko S; Stenman UH
    Clin Chem; 1998 Dec; 44(12):2471-9. PubMed ID: 9836714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ELISA for a complexed antigen with a monoclonal antibody blocking reaction with the free antigen-assay-specific for complexed prostate-specific antigen.
    Matsumoto K; Konishi N; Samori T; Kimura E; Doi M; Kato S; Yuki Y
    J Immunol Methods; 2000 Feb; 234(1-2):99-106. PubMed ID: 10669774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of acute inflammatory biomarkers in advanced prostate cancer patients with α2-macroglobulin deficiency.
    Kanoh Y; Ohtani H; Egawa S; Baba S; Akahoshi T
    Int J Oncol; 2011 Dec; 39(6):1553-8. PubMed ID: 21894431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance mechanism of prostate specific antigen and its complexes with alpha2-macroglobulin and alpha1-antichymotrypsin.
    Birkenmeier G; Struck F; Gebhardt R
    J Urol; 1999 Sep; 162(3 Pt 1):897-901. PubMed ID: 10458404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactive free : total prostate specific antigen ratios in ejaculate from men with suspected and known prostate cancer, compared with young control men.
    Clements JA; Merritt T; Devoss K; Swanson C; Hamlyn L; Scells B; Rohde P; Lavin MF; Yaxley J; Gardiner RA
    BJU Int; 2000 Sep; 86(4):453-8. PubMed ID: 10971271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen.
    Black MH; Magklara A; Obiezu CV; Melegos DN; Diamandis EP
    Clin Chem; 1999 Jun; 45(6 Pt 1):790-9. PubMed ID: 10351987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α2-Macroglobulin Is a Significant In Vivo Inhibitor of Activated Protein C and Low APC:α2M Levels Are Associated with Venous Thromboembolism.
    Martos L; Ramón LA; Oto J; Fernández-Pardo Á; Bonanad S; Cid AR; Gruber A; Griffin JH; España F; Navarro S; Medina P
    Thromb Haemost; 2018 Apr; 118(4):630-638. PubMed ID: 29448296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.